VP-102

cantharidin topical solution · Verrica Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VP-102, covering 2021-08-09 to 2026-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2) [Phase 3]